SEC Form 4 · accession 0001209191-18-036648
SURMODICS INC · SRDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bryan K Phillips
Officer — SVP, Gen Counsel & Secretary
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 3:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000924717
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 6, 2018 | S | 13,788 | $51.6235 | D | 28,099 | D | |
| Common StockF3 | Jun 6, 2018 | S | 1,212 | $52.8122 | D | 26,887 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
- F2Reflects the weighted average price of 13,788 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 6, 2018 with sale prices ranging from $51.25 to $52.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Reflects the weighted average price of 1,212 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 6, 2018 with sale prices ranging from $52.45 to $53.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.